- Home
- ALLR vs BENF Comparison
ALLR vs BENF Comparison
Compare ALLR & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- BENF
- Stock Information
- Founded
- ALLR 2004
- BENF 2003
- Country
- ALLR United States
- BENF United States
- Employees
- ALLR N/A
- BENF N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- BENF Blank Checks
- Sector
- ALLR Health Care
- BENF Finance
- Exchange
- ALLR Nasdaq
- BENF Nasdaq
- Market Cap
- ALLR 4.5M
- BENF 4.2M
- IPO Year
- ALLR N/A
- BENF N/A
- Fundamental
- Price
- ALLR $1.05
- BENF $0.78
- Analyst Decision
- ALLR
- BENF
- Analyst Count
- ALLR 0
- BENF 0
- Target Price
- ALLR N/A
- BENF N/A
- AVG Volume (30 Days)
- ALLR 218.5K
- BENF 1.4M
- Earning Date
- ALLR 11-14-2024
- BENF 11-14-2024
- Dividend Yield
- ALLR N/A
- BENF N/A
- EPS Growth
- ALLR N/A
- BENF N/A
- EPS
- ALLR N/A
- BENF N/A
- Revenue
- ALLR N/A
- BENF N/A
- Revenue This Year
- ALLR N/A
- BENF N/A
- Revenue Next Year
- ALLR N/A
- BENF N/A
- P/E Ratio
- ALLR N/A
- BENF N/A
- Revenue Growth
- ALLR N/A
- BENF N/A
- 52 Week Low
- ALLR $0.90
- BENF $0.72
- 52 Week High
- ALLR $378.00
- BENF $47.92
- Technical
- Relative Strength Index (RSI)
- ALLR 39.84
- BENF 31.59
- Support Level
- ALLR $0.90
- BENF $0.72
- Resistance Level
- ALLR $1.14
- BENF $0.85
- Average True Range (ATR)
- ALLR 0.08
- BENF 0.05
- MACD
- ALLR 0.02
- BENF 0.01
- Stochastic Oscillator
- ALLR 66.67
- BENF 10.36
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About BENF Beneficient
Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.